Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CA-125 and uterine leiomyomas

F Scarpellini1, M Minozzi, C Curto

  • 1II Institute Ob/GYN, University La Sapienza, Rome, Italy.

Acta Europaea Fertilitatis
|March 1, 1993
PubMed
Summary

Cancer antigen 125 (CA-125) shows potential as a screening marker for uterine fibroids (leiomyomatosis). This research explores its diagnostic utility in the evolving stages of this common gynecologic condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to: 'Treatment of hirsutism with myo-inositol: a prospective clinical study'.

Reproductive biomedicine online·2025
Same author

Retraction Note: The efficacy and safety of a single dose of Polyhexamethylene Biguanide gynaecologic solution versus a seven-dose regimen of vaginal clindamycin cream in patients with bacterial vaginosis.

European review for medical and pharmacological sciences·2025
Same author

Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: Long-term Results of a Prospective Phase II Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Association between endometrial senescent cells and immune cells in women with repeated implantation failure.

Journal of assisted reproduction and genetics·2023
Same author

Primary headache with onset in childhood and adolescence: natural history and prognostic factors in a Portuguese population.

Revista de neurologia·2022
Same author

Interviewing children: the impact of the COVID-19 quarantine on children's perceived psychological distress and changes in routine.

BMC pediatrics·2021

Area of Science:

  • Gynecologic Oncology
  • Biomarker Research
  • Reproductive Medicine

Background:

  • Cancer antigen 125 (CA-125) is traditionally a marker for ovarian neoplasms.
  • CA-125 has demonstrated utility in other obstetric-gynecologic conditions involving peritoneal involvement, such as endometriosis, early pregnancy, and pelvic inflammatory disease (PID).
  • Uterine leiomyomatosis (fibroids) is a prevalent condition with significant public health impact.

Purpose of the Study:

  • To investigate potential correlations between CA-125 levels and uterine leiomyomatosis.
  • To evaluate the diagnostic utility of CA-125 in the context of fibroid disease progression.
  • To explore the clinical application of CA-125 as a screening marker for uterine fibroids.

Main Methods:

  • Exploratory study investigating CA-125 levels in patients with uterine leiomyomatosis.
  • Analysis of potential correlations between CA-125 and disease characteristics.
  • Assessment of CA-125's performance as a screening and diagnostic tool.

Main Results:

  • Preliminary findings suggest a correlation between CA-125 and uterine leiomyomatosis.
  • The study indicates potential diagnostic value of CA-125 in assessing the evolution of fibroid pathology.
  • Results support the consideration of CA-125 for initial fibroid screening.

Conclusions:

  • CA-125 may serve as a valuable biomarker for uterine leiomyomatosis.
  • Clinical use of CA-125 is justified for the initial screening of fibromas.
  • CA-125 demonstrates diagnostic utility in evaluating the evolving aspects of uterine leiomyomatosis.

Related Experiment Videos